Arvinas (ARVN) FCF Margin Growth (3y) (2020 - 2026)
Arvinas (ARVN) FCF Margin Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,899.61 Bn | 65,899.33 Bn | - | - |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 471.67 Bn | 466.88 Bn | 1.35 Bn | 15,064.00 |
| 5 | Vertex Pharmaceuticals | 122.32 Bn | 115.07 Bn | 2.59 Bn | 723.00 |
| 6 | Regeneron Pharmaceuticals | 70.04 Bn | 61.29 Bn | 3.31 Bn | -1,409.00 |
| 7 | Belite Bio | 62.06 Bn | 62.06 Bn | - | - |
| 8 | Argenx Se | 55.93 Bn | 50.74 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.55 Bn | 34.54 Bn | 959.66 Mn | 6,066.00 |
| 10 | Arvinas | 530.24 Mn | -84.66 Mn | - | -16,792.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -16,792.00 |
| Dec 31, 2025 | -11,743.00 |
| Sep 30, 2025 | 5,871.00 |
| Jun 30, 2025 | -20,344.00 |
| Mar 31, 2025 | 17,610.00 |
| Dec 31, 2024 | -3,383.00 |
| Sep 30, 2024 | -746,869.00 |
| Jun 30, 2024 | 93,561.00 |
| Mar 31, 2024 | 34,190.00 |
| Dec 31, 2023 | 74,064.00 |
| Sep 30, 2023 | 1,468.00 |
| Jun 30, 2023 | 24,024.00 |
| Mar 31, 2023 | 948.00 |
| Dec 31, 2022 | 5,530.00 |
| Sep 30, 2022 | -19,158.00 |
| Jun 30, 2022 | 10,236.00 |
| Mar 31, 2022 | 10,308.00 |
| Dec 31, 2021 | 18,789.00 |
| Sep 30, 2021 | 773,398.00 |
| Jun 30, 2021 | -51,279.00 |